Management of Acute Right MCA Infarct
Immediate Emergency Department Management (Within 10 Minutes)
For acute right MCA infarct, immediately administer IV alteplase (0.9 mg/kg) if the patient presents within 3 hours of symptom onset and has no contraindications, as this provides a 35% absolute increase in favorable outcomes. 1
Upon arrival, initiate the following simultaneously:
- Perform 12-lead ECG within 10 minutes to rule out concurrent myocardial infarction, which can occur simultaneously with MCA stroke and would alter management 1
- Administer oxygen via nasal prongs immediately 1
- Obtain non-contrast head CT to exclude hemorrhage and assess early infarct signs—exclude patients with early infarct signs exceeding one-third of the MCA territory from thrombolysis 1
- Establish continuous cardiac monitoring with emergency resuscitation equipment readily available 1
Reperfusion Strategy Based on Time Window
Within 3 Hours of Symptom Onset
- Administer IV rtPA (0.9 mg/kg) immediately as first-line therapy, which reduces mortality by 21% and saves 21 lives per 1000 patients treated 1
- Do not delay IV rtPA even if considering endovascular treatment—patients eligible for IV rtPA should receive it regardless of planned intra-arterial interventions 1
3-6 Hours from Symptom Onset
- Consider intra-arterial thrombolysis with pro-urokinase (9 mg) plus low-dose IV heparin for angiographically confirmed MCA occlusion, which provides a 15% absolute benefit in achieving modified Rankin Scale ≤2 at 90 days (number needed to treat = 7) 1
- MCA occlusions have 88% recanalization rates with IV tPA compared to only 31% for ICA occlusions, making them particularly responsive to thrombolytic therapy 2
Mechanical Thrombectomy Considerations
- Stent retrievers (Solitaire FR, Trevo) are preferred over coil retrievers (Merci) for mechanical thrombectomy 1
- Mechanical thrombectomy should be performed at experienced stroke centers with rapid access to cerebral angiography and qualified interventionalists 1
- Time to reperfusion is directly correlated with outcomes—all efforts must minimize delays to definitive therapy 1
Critical Exclusion Criteria for Thrombolysis
- Early infarct signs exceeding one-third of MCA territory on baseline CT predict poor outcomes and increased hemorrhagic risk 1
- NIHSS score should be between 4-30 for intra-arterial therapy consideration 1
- Symptomatic intracranial hemorrhage occurs in 7-13% of IV rtPA patients versus 1.1% in placebo, requiring careful patient selection 1
Monitoring for Malignant MCA Infarction
Right MCA infarcts can progress to malignant infarction in approximately 10% of cases:
- Monitor for progressive neurological deterioration: worsening hemiparesis, gaze deviation, reduced consciousness, headache, vomiting 3
- Obtain follow-up CT if clinical deterioration occurs to assess for midline shift and extent of hypodensity 3
- Hypodense changes exceeding 50% of MCA territory predict malignant course with up to 80% mortality if untreated 3
- MRI with diffusion-weighted imaging is the gold standard for assessing ischemic core extent 4
Decompressive Hemicraniectomy Decision
If malignant MCA infarction develops, perform decompressive hemicraniectomy within 24 hours of symptom onset to significantly reduce mortality and improve functional outcomes. 5, 3
Favorable prognostic factors for DHC:
- Infarct volume <250 ml 5
- Midline shift <10 mm 5
- Good preoperative Glasgow Coma Scale score 5
- Absence of additional vascular territory involvement 5
- Surgery within 24 hours of ictus achieves 48.9% good functional outcome at 3 months and 64.4% at 6 months 5
Age is not a contraindication—DHC should be performed regardless of age, though patients beyond 60 years have higher likelihood of severe disability 3
Post-Acute Management
- Initiate aspirin 160-325 mg daily for secondary stroke prevention 4
- Target systolic blood pressure <120 mmHg using ACE inhibitors as preferred agents 4
- Perform carotid duplex ultrasound to identify potential stenosis causing MCA territory infarcts 4
- Obtain prolonged cardiac monitoring to screen for atrial fibrillation, as right MCA infarcts may be cardioembolic 4
- If atrial fibrillation is detected, switch from antiplatelet to anticoagulation therapy 4
Common Pitfalls to Avoid
- Do not withhold IV rtPA while arranging endovascular therapy—administer IV rtPA first if eligible 1
- Do not use thrombolysis in patients without ST-segment elevation on ECG if concurrent myocardial infarction is suspected, as this increases cardiac rupture risk 6, 7
- Do not delay DHC beyond 24 hours in malignant infarction—early intervention is critical for favorable outcomes 5, 3
- Do not exclude patients from DHC based on age alone—functional outcomes can be favorable even in elderly patients 3